Arlex Chemi Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 4.28 M
as on 16-11-2024
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 23.50 Cr
as on 16-11-2024
- Revenue 21.30%
(FY 2023)
- Profit 38.37%
(FY 2023)
- Ebitda 52.21%
(FY 2023)
- Net Worth 11.19%
(FY 2023)
- Total Assets 27.99%
(FY 2023)
About Arlex Chemi
The Corporate was formerly known as Sunrays Builders Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.28 M.
The company currently has active open charges totaling ₹23.50 Cr.
Bhavesh Shah, Sanjay Dhadve, Bhivaji Dhumal, and One other member serve as directors at the Company.
- CIN/LLPIN
U70200MH1985PTC037896
- Company No.
037896
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Arlex Chemi Private Limited offer?
Arlex Chemi Private Limited offers a wide range of products and services, including Industrial Dyes, Vat Dyes, Textile Dyes, Dyes & Color Additives, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Beauty Cosmetics, Water Dispensers, Voltas Water Dispensers.
Who are the key members and board of directors at Arlex Chemi?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavesh Shah  | Director | 24-Feb-2020 | Current |
| Sanjay Dhadve | Director | 22-Jan-2003 | Current |
| Bhivaji Dhumal | Director | 06-Jun-2009 | Current |
| Laxman Chavan | Director | 24-Feb-2020 | Current |
Financial Performance of Arlex Chemi.
Arlex Chemi Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.3% increase. The company also saw a substantial improvement in profitability, with a 38.37% increase in profit. The company's net worth Soared by an impressive increase of 11.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arlex Chemi?
In 2023, Arlex Chemi had a promoter holding of 89.37% and a public holding of 10.63%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Integrated Medicines Private LimitedActive 33 years 3 monthsBhavesh Shah and Sanjay Dhadve are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Sep 2023 | ₹15.00 Cr | Open |
Yes Bank Limited Creation Date: 14 Sep 2023 | ₹7.00 Cr | Open |
Axis Bank Limited Creation Date: 19 Mar 2020 | ₹4.96 M | Open |
How Many Employees Work at Arlex Chemi?
Arlex Chemi has a workforce of 30 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arlex Chemi, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arlex Chemi's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
